New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT07414836
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 7 times
Summary
This early-phase study tests a new drug called BG-C0979, alone or with another drug (tislelizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 84 adults with various advanced cancers will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Cabrini Hospital Malvern
RECRUITINGMalvern, Victoria, VIC 3144, Australia
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
-
Fudan University Shanghai Cancer Centerpudong
RECRUITINGShanghai, Shanghai Municipality, 201321, China
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hospital Universitario Vall Dhebron
RECRUITINGBarcelona, 08035, Spain
-
Icon Cancer Centre South Brisbane
RECRUITINGSouth Brisbane, Queensland, QLD 4101, Australia
-
John Theurer Cancer Center Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
-
Liverpool Hospital
RECRUITINGLiverpool, New South Wales, NSW 2170, Australia
-
Mengchao Hepatobiliary Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 350028, China
-
Next Oncology Madrid
RECRUITINGMadrid, 28223, Spain
-
Next Oncology San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Northern Beaches Hospital
RECRUITINGFrenchs Forest, New South Wales, NSW 2086, Australia
-
Second Affiliated Hospital of Army Medical University (Xinqiao Hospital)
RECRUITINGChongqing, Chongqing Municipality, 400037, China
-
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South)
RECRUITINGGuangzhou, Guangdong, 510245, China
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110-1010, United States
-
Yichang Central Peoples Hospital
RECRUITINGYichang, Hubei, 443003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your own immune cells beat advanced cancer?
- Tumor DNA mapping may unlock personalized cancer therapies
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a protein calm the immune System's overreaction to cancer treatment?
- Can a new drug shrink Hard-to-Treat tumors?
- Can a Custom-Made immune cell vaccine turn the tide against solid tumors?